EUVIMEDEUVIMED entdecken
Fallbericht

Topical Aprepitant (HT-001): A Novel Therapy for Epidermal Growth Factor Receptor Inhibitor-Associated Papulopustular Eruptions

Nikita Menta, Savanna I Vidal, Adam Friedman

Journal of Drugs in Dermatology · 2024

DOI: 10.36849/jdd.8617 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Drugs in Dermatology, 2024. Verfasst von Nikita Menta und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Aprepitant, Drug Eruptions, ErbB Receptors, Morpholines. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Papulopustular eruptions are the most common dermatologic side effect of epidermal growth factor receptor inhibitor (EGFRI) therapy. Topical corticosteroids and oral tetracyclines are frequently used to manage these eruptions, though these treatments are limited by their adverse effects and efficacy. Results from preclinical studies suggest a role for topical aprepitant (HT-001) in the treatment of EGFRI-induced skin toxicities. Herein a case of EGFRI-induced papulopustular eruption with rapid treatment response to topical aprepitant (HT-001) 2% cream is described and the literature reviewed. J Drugs Dermatol. 2024;23(9):e173-e174. doi:10.36849/JDD.8617.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AprepitantDrug EruptionsErbB ReceptorsMorpholinesHumansAdministration, CutaneousAntineoplastic AgentsTreatment Outcome

Substanzen

Antineoplastic AgentsAprepitantErbB ReceptorsMorpholines

Zitieren

APA

Menta, N., Vidal, S. I., & Friedman, A. (2024). Topical Aprepitant (HT-001): A Novel Therapy for Epidermal Growth Factor Receptor Inhibitor-Associated Papulopustular Eruptions. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.8617

Vancouver

Menta N, Vidal SI, Friedman A. Topical Aprepitant (HT-001): A Novel Therapy for Epidermal Growth Factor Receptor Inhibitor-Associated Papulopustular Eruptions. Journal of Drugs in Dermatology. 2024. doi:10.36849/jdd.8617

BibTeX
@article{Menta2024,
  author = {Menta, Nikita and Vidal, Savanna I and Friedman, Adam},
  title = {Topical Aprepitant (HT-001): A Novel Therapy for Epidermal Growth Factor Receptor Inhibitor-Associated Papulopustular Eruptions},
  journal = {Journal of Drugs in Dermatology},
  year = {2024},
  doi = {10.36849/jdd.8617}
}
Kostenlos starten →